Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The main goal of this study is to determine how taking efavirenz affects the levels of
pitavastatin in the bloodstream when both drugs are taken together and to see how darunavir
with ritonavir affects the levels of pitavastatin in the bloodstream. Secondary goals are to
see how taking pitavastatin affects the levels in the blood of efavirenz when both drugs are
taken together and to see how taking pitavastatin affects the levels in the blood of
darunavir.
Phase:
Phase 1
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health
Collaborators:
Bellevue/NYU AIDS Clinical Trials Unit Kowa Pharmaceuticals America, Inc. New York City Health and Hospitals Corporation University at Buffalo